Skip to main content

Research Repository

Advanced Search

Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial

Sluis, Wouter M; de Jonge, Jeroen C; Reinink, Hendrik; Wilson, Alastair; Woodhouse, Lisa J; Dawson, Jesse; Lees, Kennedy R; Bath, Philip M; van der Worp, Hendrik Bart

Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial Thumbnail


Authors

Wouter M Sluis

Jeroen C de Jonge

Hendrik Reinink

Alastair Wilson

Jesse Dawson

Kennedy R Lees

Hendrik Bart van der Worp



Abstract

Introduction:
The modified Rankin Scale (mRS) is the most frequently used primary outcome measure in acute stroke research despite significant interobserver variability in assigning grades. We assessed the use of central blinded adjudication of the mRS based on a video recording of an interview in the PRECIOUS trial.

Patients and methods:
PRECIOUS was an international, randomized, open-label, clinical trial with blinded outcome assessment of preventive treatment with metoclopramide, paracetamol, and ceftriaxone in elderly patients with acute stroke. Trained local investigators interviewed patients or their representatives and graded functional outcome at 90 days after stroke with the mRS. In each participating country, a video recording of the interview was assessed by three blinded, independent adjudicators. The primary outcome of the present substudy was interobserver agreement between the local mRS score and the median score of the three central adjudicators for patients alive at 90 days, assessed with Cohen’s kappa and quadratic weighted kappa statistics. The difference between treatment effect estimates based on local and central adjudication was a secondary outcome.

Results:
Of 1493 patients enrolled in PRECIOUS, 1471 were included in this analysis. At 90 days, 1117 patients (75.9%) were alive and had both a central and local assessment; 28 participants did not have a central mRS score. Interobserver agreement was seen in 829 (74.2%) patients and was substantial (kappa of 0.68; 95% CI 0.65–0.71). Disagreement occurred more often in patients with a central mRS score of 0–2 (OR 2.24; 95% CI 1.14–4.24). Treatment effects were neutral for all three study drugs and did not differ between central and local adjudication.

Discussion and conclusion:
Central adjudication of the mRS based on a video recording is feasible in a large international, randomized stroke trial. This ensures blinding of the outcome assessment. In this neutral trial, the impact of central adjudication on the precision of effect size estimates could not be assessed.

Citation

Sluis, W. M., de Jonge, J. C., Reinink, H., Wilson, A., Woodhouse, L. J., Dawson, J., Lees, K. R., Bath, P. M., & van der Worp, H. B. (2025). Impact of central adjudication of the score on the modified Rankin Scale in an international, randomized, acute stroke trial. European Stroke Journal, https://doi.org/10.1177/23969873251320207

Journal Article Type Article
Acceptance Date Jan 28, 2025
Online Publication Date Feb 19, 2025
Publication Date Feb 19, 2025
Deposit Date Feb 25, 2025
Publicly Available Date Feb 25, 2025
Journal European Stroke Journal
Electronic ISSN 2396-9873
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
DOI https://doi.org/10.1177/23969873251320207
Public URL https://nottingham-repository.worktribe.com/output/45599783
Publisher URL https://journals.sagepub.com/doi/10.1177/23969873251320207
Additional Information For the PRECIOUS Investigators.

Files





You might also like



Downloadable Citations